Pages that link to "Q50173471"
Jump to navigation
Jump to search
The following pages link to Increased risk of cholecystectomy in users of supplemental estrogen. (Q50173471):
Displaying 17 items.
- Alterations in gallbladder emptying and bile retention in the absence of changes in bile lithogenicity in postmenopausal women on hormone replacement therapy (Q28213650) (← links)
- Role of estrogens in the management of postmenopausal bone loss (Q34206973) (← links)
- Four decades of research on hormonal contraception. (Q35025626) (← links)
- Gallbladder disease and use of transdermal versus oral hormone replacement therapy in postmenopausal women: prospective cohort study (Q36818049) (← links)
- New insights into the molecular mechanisms underlying effects of estrogen on cholesterol gallstone formation. (Q37374183) (← links)
- Estrogen and its role in gastrointestinal health and disease (Q37572535) (← links)
- Menopause and the Aging Female Reproductive System (Q40472403) (← links)
- Relative value of transdermal and oral estrogen therapy in various clinical situations (Q40814818) (← links)
- Hormone replacement therapy and cancer (Q40877118) (← links)
- New developments in topical estrogen therapy (Q41295558) (← links)
- Obesity and cholecystectomy among women: implications for prevention. (Q50157848) (← links)
- Association of obesity and type II diabetes mellitus as a risk factor for gallstones (Q51552189) (← links)
- Bioavailability Study of Menorest®, a New Estrogen Transdermal Delivery System, Compared with a Transdermal Reservoir System. (Q54002942) (← links)
- Estrogen use and gallstone disease (Q57731643) (← links)
- Estrogen use and gallstone disease (Q68516976) (← links)
- Cost, benefits and unintended gastrointestinal side effects of pharmaceutical therapy (Q74829293) (← links)
- Hormone replacement therapy (Q77088378) (← links)